Clinical Trial Update: Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1 [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating CD34+ cell mobilization and collection in Fanconi anemia patients for subsequent FANCA gene transduction using a lentiviral v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fanconi Anemia

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Fanconi Anemia | Phase 2 | Status: COMPLETED